Cargando…
Phenotypic and genotypic characterization of meningococcal carriage and disease isolates in Burkina Faso after mass vaccination with a serogroup a conjugate vaccine
BACKGROUND: The conjugate vaccine against serogroup A Neisseria meningitidis (NmA), MenAfriVac, was first introduced in mass vaccination campaigns of the 1-29-year-olds in Burkina Faso in 2010. The aim of this study was to genetically characterize meningococcal isolates circulating in Burkina Faso b...
Autores principales: | Kristiansen, Paul A, Ba, Absatou Ky, Sanou, Idrissa, Ouédraogo, Abdoul-Salam, Ouédraogo, Rasmata, Sangaré, Lassana, Diomandé, Fabien, Kandolo, Denis, Thomas, Jennifer Dolan, Clark, Thomas A, LaForce, Marc, Caugant, Dominique A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3750508/ https://www.ncbi.nlm.nih.gov/pubmed/23914778 http://dx.doi.org/10.1186/1471-2334-13-363 |
Ejemplares similares
-
Persistent low carriage of serogroup A Neisseria meningitidistwo years after mass vaccination with the meningococcal conjugate vaccine, MenAfriVac
por: Kristiansen, Paul A, et al.
Publicado: (2014) -
Evolution of meningococcal carriage in serogroups X and Y before introduction of MenAfriVac in the health district of Kaya, Burkina Faso
por: Ba, Absatou Ky, et al.
Publicado: (2014) -
Molecular insights into meningococcal carriage isolates from Burkina Faso 7 years after introduction of a serogroup A meningococcal conjugate vaccine
por: Topaz, Nadav, et al.
Publicado: (2020) -
Meningococcal carriage 7 years after introduction of a serogroup A meningococcal conjugate vaccine in Burkina Faso: results from four cross-sectional carriage surveys
por: Mbaeyi, Sarah, et al.
Publicado: (2020) -
Molecular characterization of invasive meningococcal isolates in Burkina Faso as the relative importance of serogroups X and W increases, 2008–2012
por: Retchless, Adam C., et al.
Publicado: (2018)